On 9 March 2023, the final pitching round took place at Bank Vontobel. Four start-ups were selected from over 40 submissions to present their idea to over 70 experienced investors.
(more…)
Malvern Panalytical expands pharmaceutical drug development solutions through the acquisition of Creoptix
(Source: Press Release)
The biomedical company Hylomorph has raised 5.2 million Swiss francs in a financing round. In addition, the manufacturer received funding to allow its products to be approved for the American and European markets. (Source: Punkt4.info)
On our pitch event at October 2021 the following startups are presenting:
Isochronic, Macu4 AG, Rebels 0.0%, and Simulator GmbH.
ActLight, the Swiss technology company known for its photodiodes best-in-class signal-to-noise ratio, today announced that it has signed the second service contract based on its Single Photon Sensitivity technology with a leading company in the sensor market.
On our last pitch event at June 14th we had some very exciting startups presenting:
And the following Start-ups presented for their next financing round:
On our online pitch event at the 23 March together with Bank Vontobel we had some very exciting startups presenting:
The Start Angels Network has been actively investing in Swiss startups for more than two decades. Last year, despite the corona crisis, the club managed to invest CHF 19.7 million in 14 financing rounds for 4 new companies and 10 portfolio firms. One SAN portfolio company achieved a very valuable exit.
vVardis – the recently launched personal oral care brand by Dres Abivardi – has acquired credentis. credentis and vVardis previous partnership has already yielded the unique vVardis oral care product line, and now credentis will become the research and development department within vVardis.
hystrix medical AG, the leading e-commerce marketplace in the Swiss healthcare system for medical goods, has successfully completed a CHF3 million Series A financing round.
REad more here.
